Pregled bibliografske jedinice broj: 194171
Analysis of VEGF single nucleotide polymorphisms -1154 A/G and 936 C/T in sporadic colon cancer
Analysis of VEGF single nucleotide polymorphisms -1154 A/G and 936 C/T in sporadic colon cancer // Abstracts of the European Human Genetics Conference 2005 in European Journal of Human Genetics
Prag, 2005. str. 189-190 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 194171 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Analysis of VEGF single nucleotide polymorphisms -1154 A/G and 936 C/T in sporadic colon cancer
Autori
Čačev, Tamara ; Radošević, Senka ; Pavelić, Krešimir ; Kapitanović, Sanja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the European Human Genetics Conference 2005 in European Journal of Human Genetics
/ - Prag, 2005, 189-190
Skup
European Human Genetics Conference 2005
Mjesto i datum
Prag, Češka Republika, 07.05.2005. - 10.05.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
VEGF; SNP; sporadic colon cancer
Sažetak
Colon cancer is one of the most frequently diagnosed cancers in Western Societies. Tumor growth requires the formation of new blood vessels, a process called angiogenesis. The most important regulator of angiogenesis is vascular endothelial growth factor (VEGF) that is overexpressed in several tumors. We examined genotype and allele frequencies of two VEGF SNPs, -1154 A/G in the promotor region and 936 C/T in the 3' untranslated region. VEGF -1154 GG genotype is associated with higher VEGF expression, while -1154 AA genotype is associated with lower VEGF expression. Carriers of a 936-T allele have reduced VEGF plasma levels. VEGF low producers genotypes may confer protection, whereas high producers may have a promoting effect on tumor progression. The aim of this study was to determine wether these SNPs might influence the risk for sporadic colon cancer development and progression. A total 150 colon cancer patients and 150 unrelated cancer-free controls were genotyped for the VEGF -1154 and 936 SNPs using real-time PCR TaqMan® ; ; ; ; SNP genotyping assay and PCR-RFLP method. Genotype frequencies for VEGF -1154 were 12.6%, 49.6% and 37.6% in control population and 14.2%, 49.6% and 36.2% in colon cancer for AA, AG and GG genotype respectively. Genotype frequencies for VEGF 936 were 69.4%, 29.9% and 0.7% in control population and 69.9%, 26.7% and 3.4% in colon cancer for CC, CT and TT genotype respectively. There were no significant associations between colon cancer susceptibility and -1154 and 936 genotypes however a role of other polymorphisms within VEGF cannot be excluded.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Krešimir Pavelić
(autor)
Sanja Kapitanović
(autor)
Senka Radošević
(autor)
Tamara Čačev
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE